Bhubaneswar: After keeping its Out- Patient Department (OPD) services closed for over three months, the All India Institute of Medical Sciences (AIIMS), Bhubaneswar has decided to open the facility for patients from November 2.
"Because of the growing demands and to cater to patients'' needs, it has been decided to start the OPD services from November 2," the AIIMS, Bhubaneswar said in a statement on Thursday.
Also Read:UP: CM Yogi to launch 1250-bed OPD service at Super Specialty Cancer Institute
The OPD was closed from July 10 due to the COVID pandemic except for day-care services, radiotherapy, dialysis, trauma and the emergency and lifesaving surgery and IPD services.
Telemedicine consultation and routine check-ups through the "AIIMS Bhubaneswar Swasthya" App was continuing, it said.
Initially, the number of registrations will be restricted to 30 patients per department per day until November 8, the statement said.
It said the number of patient registrations will be increased to 50 per department per day for a week from November 9, onwards. After that, an assessment for an increase in number will be made.
Also Read:Govt Telemedicine Service Platform ESanjeevani Records 5 Lakh Teleconsultations
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!